Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD21 anticorps (FITC)

L’anticorps Souris Monoclonal anti-CD21 a été validé pour FACS, IF, IP, IHC (fro) et ICC. Il convient pour détecter CD21 dans des échantillons de Humain.
N° du produit ABIN2144534

Aperçu rapide pour CD21 anticorps (FITC) (ABIN2144534)

Antigène

Voir toutes CD21 (CR2) Anticorps
CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))

Reactivité

  • 197
  • 29
  • 29
  • 20
  • 16
  • 10
  • 6
  • 6
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 150
  • 81
  • 11
  • 1
Souris

Clonalité

  • 178
  • 62
  • 2
Monoclonal

Conjugué

  • 84
  • 25
  • 21
  • 20
  • 11
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD21 est conjugé à/à la FITC

Application

  • 151
  • 106
  • 75
  • 46
  • 39
  • 38
  • 35
  • 20
  • 19
  • 11
  • 6
  • 6
  • 6
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC)

Clone

4ABU32
  • Attributs du produit

    4ABU32 reacts with CD21 protein, a 145 kDa receptor for C3d complement fragment and for Epstein-Barr virus (EBV), expressed on all mature B lymphocytes from sIg+ stage, then lost upon activation. It also present on follicular dendritic cells and some epithelia cells. It is reported CD21 weakly expressed on the subset of mature T -cells. CD21 plays a role in B cell activation and proliferation and is part of a large signal-transduction complex containing CD19, CD81and other molecules as regulator of complement activation.This clone is cross reactive with non-human primate .*CD21 is a phenotyping marker of lymphoma.

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Procédure de l'essai

    • Take 100 μL peripheral blood anticoagulated by EDTA and add to the bottom of 5 mLtube,
    • Add 10 μL labeled antibody to the bottom of flow tube mixing with the whole blood, incubate for 20 minutes at room temperature away from light,
    • Add 2 ml1×RBC lysis buffer, incubate for 10 minutes away from light after mixing, dissolve red blood cells (recommended: RBC lysing Solution 10×,Cat.: FXP001),
    • Sample tube is set to 1000 rpm centrifugation for 5 minutes, discard the supernatant,
    • Add 2 mLPBS wash buffer to resuspend the cells, then1000 rpm centrifugation for 5 minutes, discard the supernatant,
    • Add 0.5 mLPBS wash buffer to resuspend the cells and detect by flow cytometry (sample should be determined on the day on the machine and can also be added fixation overnight at 4 °C then measured).
    • [PBS wash buffer: PBS +1 % FBS +0.1 % NaN3, Cat.: FXP005]
    • [Cell fixation: 2 % formaldehyde solution]

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Phosphate-buffered solution, pH 7.4, containing and 0.2 % (w/v) BSA

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C
  • Antigène

    CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))

    Autre désignation

    CD21

    Pathways

    Système du Complément
Vous êtes ici:
Chat with us!